Radionuclide imaging of drug delivery for patient selection in targeted therapy
S. Heskamp, H. van Laarhoven, W. van der Graaf, W. Oyen and O. BoermanArticles
Expert Opin Drug Deliv
2014
175--185
PET voor adaptatie van radiotherapieplanning bij hoofd-halscarcinomen
B. Hoeben, J. Bussink, E. Troost, O. W.J.G. and K. J.H.A.M.Articles
Nederlands Tijdschrift voor Oncologie
2014
261-267
Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression
G. Blokhuis, C. Bleeker-Rovers, M. Diender, W. Oyen, J. Draaisma and L. de Geus-OeiArticles
EJNMMI
2014
1916-1923
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients
B. Hoeben, E. Troost, J. Bussink, C. van Herpen, W. Oyen and J. KaandersArticles
Nuklearmedizin
2014
60-66
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
R. Schoffelen, W. der Woliner-van Weg, E. Visser, D. Goldenberg, R. Sharkey, W. McBride, C. Chang, E. Rossi, W. van der Graaf, W. Oyen and O. BoermanArticles
EJNMMI
2014
1593-1602
The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy
R. van Hoorn, D. Vriens, J. Postema, A. Arens, A. Pfestroff, W. Oyen and M. GotthardtArticles
NUCMC
2014
64--72
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma
O. Schuurbiers, T. Meijer, J. Kaanders, M. Looijen-Salamon, L. de Geus-Oei, M. van der Drift, E. van der Heijden, W. Oyen, E. Visser, P. Span and J. BussinkArticles
JTO
2014
1485-1493
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT
M. Boers-Sonderen, L. de Geus-Oei, I. Desar, W. van der Graaf, W. Oyen, P. Ottevanger and C. van HerpenArticles
TARONC
2014
339-347
Relationship between CT air trapping criteria and lung function in small airway impairment quantification
S. Bommart, G. Marin, A. Bourdin, N. Molinari, F. Klein, M. Hayot, I. Vachier, P. Chanez, J. Mercier and H. Vernhet-KovacsikArticles
BMCPM
2014
29
Specific targeting of tumor cells by lyophilisomes functionalized with antibodies
E. van Bracht, S. Stolle, T. Hafmans, O. Boerman, E. Oosterwijk, T. van Kuppevelt and W. DaamenArticles
Eur J Pharm Biopharm
2014
80-89
High Performance of F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
P. Brocken, H. van der Heijden, P. Dekhuijzen, L. Peters-Bax and L. de Geus-OeiArticles
Respiration
2014
32--37
Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia
D. Stevens, S. Al-Nasiry, M. Fajta, J. Bulten, A. van Dijk, M. van der Vlugt, W. Oyen, J. van Vugt and M. SpaandermanArticles
AJOG
2014
545.e1–545.e6
Preclinical Studies of SPECT and PET Tracers for NET
M. Brom, O. Boerman, M. Gotthardt and W. OyenArticles
PET Clin
2014
63--69
Non-invasive quantification of the beta cell mass by SPECT with (111)In-labelled exendin
M. Brom, W. der Woliner-van Weg, L. Joosten, C. Frielink, T. Bouckenooghe, P. Rijken, K. Andralojc, B. Göke, M. de Jong, D. Eizirik, M. Béhé, T. Lahoutte, W. Oyen, C. Tack, M. Janssen, O. Boerman and M. GotthardtArticles
Diabetologia
2014
950-959
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
M. Konijnenberg, W. Breeman, E. de Blois, H. Chan, O. Boerman, P. Laverman, P. Kolenc-Peitl, M. Melis and M. de JongArticles
EJNMMI Res
2014
47
Referred shoulder pain in a patient with small cell lung cancer. Adrenal gland metastases
W. van der Bruggen, A. Arens, M. van der Drift, L. de Geus-Oei, M. Gotthardt and W. OyenArticles
NETHJM
2013
203--206
Reply to comment by Treglia and Bertagna: FDG PET/CT for detection of infectious endocarditis
I. Kouijzer, F. Vos, M. Janssen, A. van Dijk, C. Bleeker-Rovers and W. OyenArticles
EJNMMI
2013
1114--1115
Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice
J. Cany, A. van der Waart, M. Tordoir, G. Franssen, B. Hangalapura, J. de Vries, O. Boerman, N. Schaap, R. van der Voort, J. Spanholtz and H. DolstraArticles
PLOSONE
2013
e64384